FrostPharma continues its growth journey – Magnus Nylén appointed new CEO
FrostPharma AB has experienced a strong growth trajectory in recent years, including the strategic acquisition of Abboxia. As part of accelerating the company’s development even further, Magnus Nylén will assume the role of CEO of FrostPharma starting November 3, 2025.…
Maria Lundborg29/09/2025